New York State Common Retirement Fund’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91K | Buy |
+64,200
| New | +$91K | ﹤0.01% | 2740 |
|
|
2024
Q3 | – | Sell |
-586
| Closed | -$1K | – | 3174 |
|
|
2024
Q2 | $1K | Sell |
586
-7,118
| -92% | -$12.1K | ﹤0.01% | 3267 |
|
|
2024
Q1 | $10K | Buy |
7,704
+549
| +8% | +$713 | ﹤0.01% | 3191 |
|
|
2023
Q4 | $8K | Sell |
7,155
-19,888
| -74% | -$22.2K | ﹤0.01% | 3200 |
|
|
2023
Q3 | $185K | Buy |
27,043
+232
| +0.9% | +$1.59K | ﹤0.01% | 2462 |
|
|
2023
Q2 | $278K | Sell |
26,811
-47
| -0.2% | -$487 | ﹤0.01% | 2352 |
|
|
2023
Q1 | $217K | Sell |
26,858
-19,881
| -43% | -$161K | ﹤0.01% | 2549 |
|
|
2022
Q4 | $736K | Sell |
46,739
-69
| -0.1% | -$1.09K | ﹤0.01% | 2123 |
|
|
2022
Q3 | $737K | Buy |
46,808
+7,953
| +20% | +$125K | ﹤0.01% | 2133 |
|
|
2022
Q2 | $542K | Sell |
38,855
-100
| -0.3% | -$1.4K | ﹤0.01% | 2327 |
|
|
2022
Q1 | $672K | Buy |
38,955
+7,628
| +24% | +$132K | ﹤0.01% | 2280 |
|
|
2021
Q4 | $455K | Sell |
31,327
-20
| -0.1% | -$290 | ﹤0.01% | 2479 |
|
|
2021
Q3 | $564K | Sell |
31,347
-5,853
| -16% | -$105K | ﹤0.01% | 2397 |
|
|
2021
Q2 | $653K | Buy |
+37,200
| New | +$653K | ﹤0.01% | 2452 |
|
|
2020
Q2 | – | Sell |
-29,649
| Closed | -$31K | – | 3211 |
|
|
2020
Q1 | $31K | Hold |
29,649
| – | – | ﹤0.01% | 3061 |
|
|
2019
Q4 | $56K | Hold |
29,649
| – | – | ﹤0.01% | 3109 |
|
|
2019
Q3 | $32K | Hold |
29,649
| – | – | ﹤0.01% | 3185 |
|
|
2019
Q2 | $65K | Hold |
29,649
| – | – | ﹤0.01% | 3182 |
|
|
2019
Q1 | $178K | Hold |
29,649
| – | – | ﹤0.01% | 2769 |
|
|
2018
Q4 | $219K | Hold |
29,649
| – | – | ﹤0.01% | 2672 |
|
|
2018
Q3 | $431K | Hold |
29,649
| – | – | ﹤0.01% | 2481 |
|
|
2018
Q2 | $592K | Buy |
29,649
+5,900
| +25% | +$118K | ﹤0.01% | 2379 |
|
|
2018
Q1 | $416K | Hold |
23,749
| – | – | ﹤0.01% | 2430 |
|
|
2017
Q4 | $586K | Buy |
23,749
+2,200
| +10% | +$54.3K | ﹤0.01% | 2288 |
|
|
2017
Q3 | $556K | Sell |
21,549
-2,112
| -9% | -$54.5K | ﹤0.01% | 2309 |
|
|
2017
Q2 | $642K | Buy |
23,661
+10,877
| +85% | +$295K | ﹤0.01% | 2287 |
|
|
2017
Q1 | $381K | Sell |
12,784
-2,862
| -18% | -$85.3K | ﹤0.01% | 2505 |
|
|
2016
Q4 | $425K | Buy |
15,646
+1,434
| +10% | +$39K | ﹤0.01% | 2436 |
|
|
2016
Q3 | $364K | Buy |
14,212
+2,863
| +25% | +$73.3K | ﹤0.01% | 2474 |
|
|
2016
Q2 | $210K | Buy |
11,349
+8,900
| +363% | +$165K | ﹤0.01% | 2706 |
|
|
2016
Q1 | $46K | Buy |
+2,449
| New | +$46K | ﹤0.01% | 3073 |
|